RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
124 hedge funds and large institutions have $900M invested in Ra Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
+30
Holders Change %
+31.91%
% of All Funds
2.69%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
34
Increased
44
Reduced
30
Closed
4
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$348K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$20.9M |
| 2 |
BlackRock
New York
|
$71.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$7.23M |
| 4 |
UBS AM
Chicago,
Illinois
|
$7.05M |
| 5 |
GTC
Ghost Tree Capital
New York
|
$6.72M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$195K | -10,736 | Closed |
|
|
TRCT
127
Tower Research Capital (TRC)
New York
| – | -$44K | -2,397 | Closed |
|